Detalhe da pesquisa
1.
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Cancer Immunol Immunother
; 72(1): 91-99, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729418
2.
Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapy.
EJNMMI Phys
; 10(1): 79, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38062278
3.
Case Report: Long-term metabolic response of metastatic uveal melanoma to pembrolizumab on FDG-PET/CT despite a serial pseudoprogressions phenomenon.
Front Immunol
; 14: 1243208, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111583
4.
HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker.
Front Immunol
; 14: 1285895, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299143
5.
Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.
Sci Rep
; 13(1): 5789, 2023 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031233
6.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
J Cancer Res Clin Oncol
; 149(16): 15095-15102, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626173
7.
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
J Immunother
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807621
8.
Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Clin Nucl Med
; 47(7): e506-e508, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426872
9.
Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT.
Front Med (Lausanne)
; 9: 1078560, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606046
10.
Incidental Findings of a Vestibular Schwannoma on 18F-Choline PET/CT.
Clin Nucl Med
; 46(2): e75-e77, 2021 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234934
11.
Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer.
Front Med (Lausanne)
; 8: 691253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34660618
12.
Case Report: Nasal Cavity Epithelial-Myoepithelial Carcinoma With High Fluoro-D-Glucose Uptake on Positron Emission Tomography/Computed Tomography.
Front Med (Lausanne)
; 8: 664520, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993207
13.
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors.
Sci Rep
; 11(1): 4727, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649421
14.
Complete Metabolic Response Assessed by FDG PET/CT to FOLFOXIRI-Bevacizumab in First-Line Treatment of BRAFV600E Mutated Metastatic Colorectal Cancer.
Clin Nucl Med
; 45(9): 707-708, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657876
15.
Complete Metabolic Response Assessed by FDG PET/CT to Paclitaxel-Ramucirumab in Patients With Metastatic Gastroesophageal Junction Cancer.
Clin Nucl Med
; 45(2): 127-128, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876811
16.
Duration of nivolumab for pretreated, advanced non-small-cell lung cancer.
Cancer Med
; 9(19): 6923-6932, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32412157
17.
First-line pembrolizumab for non-small cell lung cancer patients with PD-L1 ≥50% in a multicenter real-life cohort: The PEMBREIZH study.
Cancer Med
; 9(7): 2309-2316, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32022459
18.
Complete Metabolic Response Assessed by FDG PET/CT to FOLFIRI-Aflibercept in Second-Line Treatment of Metastatic Colorectal Cancer.
Clin Nucl Med
; 44(7): 578-579, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107745
19.
Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma.
Medicine (Baltimore)
; 98(29): e16417, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335691
20.
Author Correction: Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.
Sci Rep
; 13(1): 6665, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095194